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Clinicians should not routinely recommend elec-tronic nicotine delivery devices (ENDS), such as e-cigarettes, to their patients who smoke. 
The wisdom of this evidenced-based recommendation 
stems from 4 key issues: inadequate safety, poor effec-
tiveness, little regulation, and an ethical framework to 
do no harm.
First, we lack strong evidence in regard to the safety 
of ENDS, and evidence exists about potential and real 
harms. While many studies report lower levels of toxi-
cants in ENDS compared with conventional cigarettes,1 
the belief that ENDS are thus safe is false. ENDS 
appear to deliver a similar number of particulate matter 
as cigarettes,2 and exposure to particles increases risks 
for cardiovascular and respiratory disease,3,4 raising con-
cern that particulate matter in ENDS may have similar 
adverse effects. Potentially cytotoxic or nephrotoxic 
effects of ENDS are also emerging.5,6 Finally, virtually 
all ENDS products utilize flavorings, and the inhala-
tion of flavor additives, such as diacetyl, is a recognized 
health hazard associated with respiratory disease, 
including bronchiolitis obliterans, commonly known as 
“Popcorn Lung”.7,8 Long-term inhalation of flavorings 
and other chemicals found in ENDS, even at low con-
centrations, is a safety concern.9
Second, the effectiveness of ENDS as a smoking 
cessation aid is questionable at best, potentially inef-
fective at worst, and significantly poorer than existing 
FDA-approved optimal therapies, such as combined 
nicotine replacement therapy (NRT) or varenicline, 
with intensive behavioral treatment. Results from 2 
randomized controlled trials suggest that ENDS may 
help some smokers stop smoking, but the quality of 
evidence was rated as low.10 On the contrary, a meta-
analysis of 4 population-based longitudinal studies and 
1 cross-sectional study indicated ENDS use is associ-
ated with significantly lower odds of quitting smoking 
cigarettes.9 Whether ENDS help or hurt a patient’s 
chances of quitting, as of today, they are significantly 
less effective than existing best practices.11
Third, until regulations are approved by authori-
ties, clinicians should pause for thought before recom-
mending ENDS. Lack of regulation has resulted in 
battery and other safety concerns, resulting in over-
heating, fire, and explosions, with damaging, disfigur-
ing, and life-threatening consequences to users and 
non-users.12 Poisonings from ENDS exposure, particu-
larly for young children, has increased exponentially 
in the last 5 years.13 From a regulatory approach, 
nicotine concentrations found in ENDS can be mark-
edly different than the labeled content, and some 
supposedly nicotine-free products contain varying 
concentrations of nicotine.1 Finalizing pending FDA 
regulations of ENDS in the United States would be a 
significant step forward.
 Finally, the ethical duty of medicine is to do no 
harm. Jumping from the 10th floor of a burning build-
ing rather than the 15th floor offers no real benefit. If 
a clinician recommends penicillin for a resistant infec-
tion in the face of more effective therapy, they would 
face an uncertain defense in front of their colleagues 
or courts. For clinicians that do recommend ENDS, do 
they document such in the medical record? Given the 
rise in medical lawsuits related to ENDS side effects or 
injuries,14,15 until such time that medical evidence sup-
ports ENDS safety and effectiveness, and robust regu-
latory frameworks exist, clinicians who recommend 
ENDS to patients in favor of more effective and safe 
products16 may face medico-legal risks.
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Some clinicians may be tempted to recommend 
ENDS for certain subgroups of smokers, but this 
approach is problematic. Pregnant women may think 
ENDS use in pregnancy is safe and avoid quitting 
tobacco entirely in pregnancy in favor of switching to 
ENDS.17 No trials, however, have evaluated the safety of 
ENDS use during pregnancy18 and cells from embryos 
and newborns have shown greater cytoxicity to ENDS 
fluid than adult cells.19 It is problematic to recommend 
ENDS for asthmatic tobacco users, as immediate reduc-
tion in lung function is observed when using ENDS.20,21 
Perhaps most importantly, the impact of increased 
ENDS use among youth has generated national and 
international concern.22,23 In adolescents, ENDS use is 
associated with increased odds of being diagnosed with 
asthma and increased asthma severity24 and is also asso-
ciated with lower cigarette smoking abstinence.25
One thing perhaps all clinicians can agree on is 
that patients need more help from providers in quitting 
tobacco use. The good news is that clinicians already 
have adequate tools at their disposal. Best practices 
(ie, combined behavioral support and FDA-approved 
pharmacotherapy) provide safe and effective treatment 
for smoking cessation, increasing quit rates by two- to 
threefold.11 Encouraging clinicians to utilize such best 
practices should be a priority. Until more independent 
data on ENDS safety and effectiveness emerges, clini-
cians should be advised against routinely recommend-
ing ENDS to their patients who smoke.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/content/14/4/302.
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